Going anti-Viral
Introducing Going anti-Viral, the podcast of the IAS–USA, a professional continuing medical education organization focused on HIV and other viral diseases. I’m Dr Michael Saag, professor emeritus of medicine and infectious diseases at the University of Alabama at Birmingham and volunteer member of the IAS–USA Board of Directors.
Join us as we interview experts in viral medicine about their area of specialty and current developments in the field. Other episodes are drawn from the IAS-USA vast catalogue of panel discussions, Dialogues, and various meetings and conferences.
Going anti-Viral is a podcast series for clinicians, produced by the International Antiviral Society–USA. The IAS–USA is a not-for-profit professional organization committed to improving the treatment, care, and quality of life for people with or at risk for HIV or other viral infections and their complications through balanced education and information. This podcast is intended as a clinical source of information for specialists in this field, but we hope anyone listening will enjoy learning more about the state of modern medicine around viral infections and their consequences.
Episodes
63 episodes
The COVID-19 Pandemic and the Current State of Public Health in the US – Dr Rochelle Walensky
In episode 62 of Going anti-Viral, Dr Rochelle Walensky joins host Dr Michael Saag on World AIDS Day 2025 to discuss her experience as the Director of the Centers for Disease Control and Prevention (CDC) during the COVID-19 pandemic an...
•
Season 1
•
Episode 62
•
34:41
The Evidence for Vaccine Safety and Effectiveness – Dr Yvonne Maldonado
In episode 61 of Going anti-Viral, Dr Yvonne Maldonado joins host Dr Michael Saag to discuss the evidence for vaccine safety and effectiveness. Dr Maldonado is a Professor in the Stanford University School of Medicine where she has ach...
•
Season 1
•
Episode 61
•
39:10
Medical Cannabis: Evidence and Insight with Dr Donald Abrams
In episode 60 of Going anti-Viral, Dr Donald Abrams joins host Dr Michael Saag to discuss medical cannabis. Dr Abrams is a professor emeritus at the University of California San Francisco and a specialist in integrative oncology at the...
•
Season 1
•
Episode 60
•
29:34
The CDC without Scientific Leadership - Dr Demetre Daskalakis
In episode 59 of Going anti-Viral, Dr Demetre Daskalakis joins host Dr Michael Saag to discuss his career in public health and the turnover in leadership at the US Centers for Disease Control and Prevention (CDC). Dr Daskalakis is an i...
•
Season 1
•
Episode 59
•
37:18
Demystifying Syphilis: Diagnosis and Treatment – Dr Khalil Ghanem
In episode 58 of Going anti-Viral, Dr Khalil Ghanem joins host Dr Michael Saag to discuss current challenges in the diagnosis and treatment of syphilis. Dr Ghanem is a Professor of Medicine in the Division of Infectious Diseases at Joh...
•
Season 1
•
Episode 58
•
30:50
A Personal Journey with HIV and Advocacy for HIV Research – Dawn Averitt
In episode 57 of Going anti-Viral, Dawn Averitt joins host Dr Michael Saag to discuss HIV advocacy and the importance of scientific research. Ms Averitt is a social justice advocate and founder of organizations focused on women with HI...
•
Season 1
•
Episode 57
•
30:31
The Management of Cardiovascular Health in Patients with HIV – Dr Steven Grinspoon
In episode 56 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to discuss managing cardiovascular health in people with HIV. Dr Grinspoon is a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and f...
•
Season 1
•
Episode 56
•
27:24
Navigating HIV Care with GLP-1 Receptor Agonists – Dr Darcy Wooten
In episode 55 of Going anti-Viral, Dr Darcy Wooten joins host Dr Michael Saag to discuss navigating HIV care with glucagon-like peptide-1 (GLP-1) receptor agonists. Dr Wooten is a Professor of Medicine in the Division of Infectious Dis...
•
Season 1
•
Episode 55
•
24:42
Treating Substance Use Disorder in an Inpatient Setting - Dr Ellen Eaton
In episode 54 of Going anti-Viral, Dr Ellen Eaton joins host Dr Michael Saag to discuss the treatment of substance use disorder in an in-patient setting. Dr Eaton is an Associate Professor in the Department of Medicine and Division of ...
•
Season 1
•
Episode 54
•
31:09
Update on Emerging Infectious Diseases – Dr George Rutherford
In episode 53 of Going anti-Viral, Dr George Rutherford joins host Dr Michael Saag to provide an update on emerging infectious diseases. Dr Rutherford is a Professor Emeritus of Epidemiology, Preventive Medicine, Pediatrics and History...
•
Season 1
•
Episode 53
•
29:50
Providing Healthcare to Foreign-Born and Hard-to-Reach Individuals – Dr Carlos del Rio
In episode 52 of Going anti-Viral, Dr Carlos del Rio joins host Dr Michael Saag to discuss the topic of providing care to foreign-born individuals. Dr del Rio is a Distinguished Professor of Medicine in the Division of Infectious Disea...
•
Season 1
•
Episode 52
•
29:41
The Measles Outbreak and the Role Anti-Science Plays in Threatening Public Health – Dr Peter Hotez
In episode 51 of Going anti-Viral, Dr Peter Hotez joins host Dr Michael Saag to provide an update on the measles outbreak in the US and discuss the role that anti-science plays in threatening public health. Dr Hotez is a Professor of P...
•
Season 1
•
Episode 51
•
34:16
How Vaccines Get Approved in the US: The RSV Story and the Role of the ACIP – Dr Yvonne Maldonado
In episode 50 of Going anti-Viral, Dr Yvonne Maldonado joins host Dr Michael Saag to discuss the respiratory syncytial virus (RSV) vaccine and the vaccine approval process in the United States. Dr Maldonado is a Professor in the Stanfo...
•
Season 1
•
Episode 50
•
35:40
Next-Gen HIV Prevention and Treatment – Dr Judith Currier
In episode 49 of Going anti-Viral, Dr Judith Currier joins host Dr Michael Saag to discuss Next-Gen HIV Prevention and Treatment. Dr Currier is a Professor of Medicine at UCLA and has more than 25 years of experience in the de...
•
Season 1
•
Episode 49
•
30:14
Episode 48 – Breaking the Silence: An Activist’s Approach, with Mary Fisher
In this episode of Going anti-Viral, Mary Fisher joins host Dr Michael Saag to discuss Communicating the Importance of Science and Research to the Public. Ms Fisher is an artist, author, and activist, who has spent a lifetime ...
•
Season 1
•
Episode 48
•
34:58
Episode 47 – 40+ Years of HIV: What’s Changed, What Hasn’t, What Shouldn’t, What Must – Rebecca Denison
In this episode of Going Anti-Viral, Rebecca Denison joins host Dr Michael Saag as a follow-up discussion to her Martin Delaney presentation at CROI 2025: 40+ Years of HIV: What’s Changed, What Hasn’t, What Shouldn’t, What Must. Ms Denison is a...
•
Season 1
•
Episode 47
•
30:01
Episode 46 – Development of a Hepatitis C Cure – Dr Raymond Schinazi
In this episode of Going Anti-Viral, Dr Raymond Schinazi joins host Dr Michael Saag for an in-depth conversation about the development of a cure for hepatitis C. Dr Schinazi, the Frances Winship Walters Professor of Pediatrics and Director of t...
•
Season 1
•
Episode 46
•
29:53
Episode 45 – Bacteriophages for the treatment of antimicrobial-resistant (AMR) bacterial infections – Dr Graham Hatfull
In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Graham Hatfull, a Professor of Biological Sciences at the University of Pittsburgh. Dr Hatfull joins Dr Saag to discuss Bacteriophages for the treatment of anti...
•
Season 1
•
Episode 45
•
32:09
Episode 44 – IAS–USA 2025 Update of the Drug Resistance Mutations in HIV-1 – Dr Annemarie Wensing
In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Annemarie M. Wensing, a Clinical Virologist at the University Medical Center Utrecht and an Honorary Professor at the University of the Witwatersrand in Johannesburg. ...
•
Season 1
•
Episode 45
•
27:51
Episode 43 – Innovations in HIV Service Delivery: Building a Path Forward with Those Left Behind
In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Izukanji Sikazwe, the Chief Executive Officer for the Centre for Infectious Disease Research in Zambia (CIDRZ). Dr Sikazwe joins Dr Saag to provide an overview of her ...
•
Season 1
•
Episode 43
•
29:46
Special Episode: 40+ Years of HIV: What’s Changed, What Hasn’t, What Shouldn’t, What Must
This episode of Going anti-Viral, features Rebecca Denison, who gave the Martin Delaney Presentation, entitled 40+ Years of HIV: What’s Changed, What Hasn’t, What Shouldn’t, What Must, at the 2025 Conference on Retroviruses an...
•
Season 1
•
Episode 43
•
34:38
Episode 41 – Meeting the Treatment and Prevention Needs of Transgender Women - Dr Tonia Poteat
In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Tonia Poteat, a professor in the Duke University School of Nursing and co-director of the Duke SGM Wellness Program. Dr Poteat joins Dr Saag to provide an overview of ...
•
Season 1
•
Episode 41
•
23:16
Episode 40 – HIV Cure Research: State of the Art and Navigating Presentations at CROI 2025
In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Joseph Eron, Professor of Medicine at University of North Carolina (UNC) about the topic of his upcoming presentation at the Conference on Retroviruses and Opportunist...
•
Season 1
•
Episode 40
•
27:31
Episode 39 - Preview of the 2025 Conference on Retroviruses and Opportunistic Infections (CROI)
In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Diane Havlir, Professor of Medicine at the University of California San Francisco. Dr Havlir currently serves as Chair of the Scientific Program Committee for the 2025...
•
Season 1
•
Episode 39
•
26:04
Episode 38 - Update on COVID-19 with Dr Andy Pavia
In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Andy Pavia of the University of Utah for an update on COVID-19. Dr Pavia and Dr Saag review COVID-19 cases and deaths in 2024 including a discussion about the reasons ...
•
Season 1
•
Episode 38
•
31:36